Strategic Expansion Astorg has a track record of acquiring and scaling platform plays across Europe and the US, with recent activity including Thermo Fisher and CareDx assets, plus growth through mid-cap investments. This suggests opportunities to engage with portfolio companies undergoing strategic realignments, buy-and-build initiatives, or add-on acquisitions.

Healthcare and Tech Focus Astorg emphasizes healthcare, software, technology, and tech-enabled industrials, positioning as a partner for growth in high-margin, tech-driven sectors. Target outreach to healthcare diagnostics, biotech tooling, and software-enabled services that align with Astorg's domain expertise.

Private Equity Growth Partners With over €24 billion AUM and a lean, long-term ownership approach, Astorg presents as a patient capital partner ideal for companies seeking governance enhancements, scale, and international expansion rather than short-term exits.

Global Footprint Headquartered in Luxembourg with offices in major European and US markets, Astorg can facilitate cross-border growth, geographic diversification, and complex international transactions, offering value in multi-region deal structures.

Fundraising Readiness Recent mid-cap fund development and leadership appointments indicate ongoing fundraising activity and capacity for new deals, presenting an opening to identify co-investment or continuation-fund opportunities, especially with mid-market targets.